The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

Published:2024-09 Issue: Volume:129 Page:102787
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Zhang Yaowen,Chen Junru,Liu Haoyang,Dai Jindong,Zhao Junjie,Zhu Sha,Zhang Xingming,Liang Jiayu,Hu Xu,Zhao Jinge,Liu Zhenhua,Shen Pengfei,Sun Guangxi,Zeng Hao

Funder

National Natural Science Foundation of China

Sichuan University

China Postdoctoral Science Foundation

Sichuan Province Science and Technology Support Program

Sichuan University West China Hospital

Publisher

Elsevier BV

Reference86 articles.

1. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy;Tang;Sig Transduct Target Ther,2021

2. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance;Bagchi;Annu Rev Pathol Mech Dis,2021

3. Immuno-oncology advances in genitourinary cancers;Zang;Am Soc Clin Oncol Educ Book,2024

4. Immunotherapy and checkpoint inhibitors in urologic cancer;Walasek;Urol Clin N Am,2022

5. Open-label, single-arm phase ii study of pembrolizumab monotherapy as first-line therapy in patients with advanced clear cell renal cell carcinoma;McDermott;JCO,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP